PI
ABBV icon

PFS Investments’s AbbVie ABBV Stock Holding History

PFS Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$49.8M Buy
369,535
+16,371
+5% +$2.4M 0.81% 26
2023
Q1 		$57.1M Buy
353,164
+53,633
+18% +$8.2M 0.99% 18
2022
Q4 		$48.4M Sell
299,531
-1,794
-0.6% -$275K 0.9% 18
2022
Q3 		$40.4M Buy
301,325
+31,186
+12% +$4.48M 0.73% 19
2022
Q2 		$41.4M Buy
270,139
+36,648
+16% +$5.6M 0.83% 20
2022
Q1 		$37.9M Sell
233,491
-52,813
-18% -$7.67M 0.72% 31
2021
Q4 		$38.8M Buy
286,304
+25,637
+10% +$3.03M 0.75% 31
2021
Q3 		$30.3M Buy
260,667
+22,716
+10% +$2.6M 0.63% 45
2021
Q2 		$27.7M Buy
237,951
+47,821
+25% +$5.39M 0.63% 39
2021
Q1 		$20.6M Buy
190,130
+27,185
+17% +$2.91M 0.53% 51
2020
Q4 		$17.8M Buy
162,945
+20,705
+15% +$1.99M 0.5% 56
2020
Q3 		$12.5M Buy
142,240
+18,540
+15% +$1.75M 0.41% 57
2020
Q2 		$12.1M Buy
123,700
+44,194
+56% +$3.89M 0.45% 54
2020
Q1 		$6.06M Sell
79,506
-261
-0.3% -$22.2K 0.26% 67
2019
Q4 		$7.06M Buy
79,767
+19,057
+31% +$1.58M 0.27% 71
2019
Q3 		$4.6M Buy
60,710
+18,890
+45% +$1.3M 0.2% 77
2019
Q2 		$3.05M Buy
41,820
+31,794
+317% +$2.5M 0.14% 73
2019
Q1 		$808K Buy
+10,026
New +$820K 0.04% 111

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PFS Investments's ABBV Position: Q2 2023 in Review

PFS Investments increased its AbbVie (ABBV) stake by 4.6% in Q2 2023, buying an estimated $2.4M and bringing the position to 369,535 shares worth $49.8M. The position accounts for 0.81% of the portfolio, ranked #26.

PFS Investments first reported a position in ABBV in Q1 2019 and has held it in 18 quarters since. The position peaked at $57.1M in Q1 2023. 3,079 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • PFS Investments held 369,535 shares of AbbVie worth $49.8M as of Q2 2023.
  • PFS Investments bought 16,371 AbbVie shares in Q2 2023, an estimated $2.4M.
  • AbbVie made up 0.81% of PFS Investments's portfolio in Q2 2023, its #26 holding.
  • PFS Investments first reported a position in AbbVie in Q1 2019 and has held it in 18 quarters since.
  • PFS Investments's AbbVie position peaked at $57.1M in Q1 2023.
  • 3,079 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.